Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53(+/-) mice

Documenti analoghi

• Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice
  di: Blackburn, AC, et al.
  Pubblicazione: (2012)
• Dichloroacetate is an effective treatment for sarcoma models in vitro and in vivo
  di: Rooke, Melissa, et al.
  Pubblicazione: (2014)
• Inherited TP53 Mutations and the Li–Fraumeni Syndrome
  di: Guha, Tanya, et al.
  Pubblicazione: (2017)
• Hormonal control of p53 and chemoprevention
  di: Jerry, D Joseph, et al.
  Pubblicazione: (2002)
• Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties
  di: Galgamuwa, Ramindhu, et al.
  Pubblicazione: (2016)